Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...
A social media post claims that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic. After fact checking, ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
Explore the truth behind false claims that Moderna's CEO confessed to creating a COVID-19 vaccine before the pandemic, and the context of his remarks on vaccine production.
As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
In response, Moderna has slashed 2025 guidance twice in the past four months, most recently just eight days after CEO Stephane Bancel wrote in his Moderna 2024 Shareholder Letter that “There are ...
Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence. The maker of vaccines, including the mRNA vaccine for COVID-19, is ...
It expects to end 2025 with a cash balance of $6 billion. Moderna CEO Stephane Bancel commented, "In 2024, we achieved $3.0 - 3.1 billion in product sales, approval of our RSV vaccine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results